compound, pharmaceutical composition, pask inhibition method, method of treating a disease, method for achieving an effect on a patient, and method of treating a pask-mediated disease
Disclosed herein are substituted quinoxaline carboxylic acids of Formula (I): and compositions thereof, which may be useful as inhibitors of PAS Kinase (PASK) activity in a human or animal for the treatment of diseases such as diabetes mellitus.